The Israeli Forum for Prevention of Cardiovascular Disease, Barzilai Medical Center Campus Ashkelon, Ben-Gurion University, Israel.
Cost Eff Resour Alloc. 2007 Nov 28;5:16. doi: 10.1186/1478-7547-5-16.
This study aims to calculate the health effects and costs of a proposed national hypertension prevention and control program.
Interventions are based on experience from our two programs: 10-year period of Ashkelon Hypertension Detection and Control Program (AHDC Program) and the Israel Blood Pressure Control (IBPC) program. The costs of a nationwide program were calculated based on economic data, training staff levels, course frequency and unit costs.
Over the next 20 years, the program should decrease the risk in one-half of the treated hypertensive cases of the following ailments: cardiovascular events such as Acute Myocardial Infarction (AMI) and Unstable Angina Pectoris (UAP) by 16.0%, stroke by 41.2%, End stage renal disease (ESRD) by 50.0% and peripheral vascular disease (PVD) by 42.6%. In total, around 2,242 lives, 35,117 years of life or 24,433 disability adjusted life years will be saved due to decreased mortality.Program costs amount to $352.7 million. However savings ($537.6 million), from reduced medical treatment ($444.3 million) and reduced pharmaceutical use ($93.3 million) as a result of morbidity decreases, exceed costs by $185.0 million.
The project which saves both lives and resources should be extended nation-wide to reach as wide a population as possible.
本研究旨在计算拟议的国家高血压预防和控制计划的健康影响和成本。
干预措施基于我们的两个项目的经验：为期 10 年的阿什凯隆高血压检测和控制计划（AHDC 计划）和以色列血压控制（IBPC）计划。根据经济数据、培训员工水平、课程频率和单位成本，计算了全国性计划的成本。
在未来 20 年内，该计划应降低以下疾病的治疗高血压病例中一半的风险：心血管事件，如急性心肌梗死（AMI）和不稳定型心绞痛（UAP）减少 16.0%，中风减少 41.2%，终末期肾病（ESRD）减少 50.0%，外周血管疾病（PVD）减少 42.6%。总的来说，由于死亡率降低，大约有 2242 人、35117 年的生命或 24433 年的残疾调整生命年将被挽救。计划成本为 3.527 亿美元。然而，由于发病率降低而减少的医疗费用（4.443 亿美元）和减少的药物使用（9330 万美元）的节省额超过了 1.85 亿美元。
该项目既能挽救生命又能节约资源，应在全国范围内推广，以覆盖尽可能多的人群。
